(ALSN) Allison Transmission - Overview
Sector: Consumer CyclicalIndustry: Auto Parts | Exchange NYSE (USA) | Currency USD | Market Cap: 9.213m | Total Return 18.4% in 12m
Stock: Transmissions, Propulsion Systems, Replacement Parts
Total Rating 58
Risk 90
Buy Signal -0.37
| Risk 5d forecast | |
|---|---|
| Volatility | 29.5% |
| Relative Tail Risk | -8.18% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.58 |
| Alpha | 3.76 |
| Character TTM | |
|---|---|
| Beta | 1.047 |
| Beta Downside | 0.801 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.59% |
| CAGR/Max DD | 1.19 |
EPS (Earnings per Share)
Revenue
Description: ALSN Allison Transmission March 04, 2026
Allison Transmission Holdings Inc. (ALSN) manufactures and sells automatic transmissions for commercial and defense vehicles, and electrified propulsion systems.
The companys products serve diverse applications including distribution, refuse, construction, and public transportation. This business model relies on strong relationships with Original Equipment Manufacturers (OEMs).
ALSN also sells replacement parts, support equipment, and offers engineering services and extended warranty coverage, supporting a significant installed base of vehicles. The heavy-duty vehicle market is cyclical and sensitive to economic conditions.
Explore ValueRay for more in-depth analysis of ALSNs financial performance and market position.
Headlines to watch out for
- Commercial vehicle production directly impacts transmission sales
- Defense spending fluctuations affect military vehicle orders
- Raw material costs influence manufacturing profitability
- Global economic conditions dictate commercial vehicle demand
- Electrified propulsion system adoption drives future revenue
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 623.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA -0.62 > 1.0 |
| NWC/Revenue: 58.90% < 20% (prev 32.0%; Δ 26.90% < -1%) |
| CFO/TA 0.14 > 3% & CFO 830.0m > Net Income 623.0m |
| Net Debt (1.43b) to EBITDA (1.01b): 1.40 < 3 |
| Current Ratio: 4.85 > 1.5 & < 3 |
| Outstanding Shares: last quarter (84.0m) vs 12m ago -3.46% < -2% |
| Gross Margin: 48.54% > 18% (prev 0.47%; Δ 4.81k% > 0.5%) |
| Asset Turnover: 52.72% > 50% (prev 60.44%; Δ -7.71% > 0%) |
| Interest Coverage Ratio: 9.74 > 6 (EBITDA TTM 1.01b / Interest Expense TTM 92.0m) |
Altman Z'' 2.92
| A: 0.29 (Total Current Assets 2.23b - Total Current Liabilities 460.0m) / Total Assets 6.08b |
| B: -0.01 (Retained Earnings -38.0m / Total Assets 6.08b) |
| C: 0.16 (EBIT TTM 896.0m / Avg Total Assets 5.71b) |
| D: -0.02 (Book Value of Equity -93.0m / Total Liabilities 4.21b) |
| Altman-Z'' Score: 2.92 = A |
Beneish M -3.21
| DSRI: 0.99 (Receivables 333.0m/360.0m, Revenue 3.01b/3.23b) |
| GMI: 0.98 (GM 48.54% / 47.35%) |
| AQI: 0.87 (AQ_t 0.49 / AQ_t-1 0.56) |
| SGI: 0.93 (Revenue 3.01b / 3.23b) |
| TATA: -0.03 (NI 623.0m - CFO 830.0m) / TA 6.08b) |
| Beneish M-Score: -3.21 (Cap -4..+1) = AA |
What is the price of ALSN shares?
As of March 27, 2026, the stock is trading at USD 116.32 with a total of 481,123 shares traded.
Over the past week, the price has changed by +3.68%, over one month by -6.57%, over three months by +15.53% and over the past year by +18.40%.
Over the past week, the price has changed by +3.68%, over one month by -6.57%, over three months by +15.53% and over the past year by +18.40%.
Is ALSN a buy, sell or hold?
Allison Transmission has received a consensus analysts rating of 3.30.
Therefor, it is recommend to hold ALSN.
- StrongBuy: 2
- Buy: 1
- Hold: 5
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the ALSN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 130.5 | 12.2% |
| Analysts Target Price | 130.5 | 12.2% |
ALSN Fundamental Data Overview March 23, 2026
P/E Trailing = 15.1023
P/E Forward = 12.3457
P/S = 3.0609
P/B = 4.9098
P/EG = 0.6667
Revenue TTM = 3.01b USD
EBIT TTM = 896.0m USD
EBITDA TTM = 1.01b USD
Long Term Debt = 2.88b USD (from longTermDebt, last quarter)
Short Term Debt = 10.0m USD (from shortTermDebt, last quarter)
Debt = 2.92b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.43b USD (from netDebt column, last quarter)
Enterprise Value = 10.64b USD (9.21b + Debt 2.92b - CCE 1.50b)
Interest Coverage Ratio = 9.74 (Ebit TTM 896.0m / Interest Expense TTM 92.0m)
EV/FCF = 14.94x (Enterprise Value 10.64b / FCF TTM 712.0m)
FCF Yield = 6.69% (FCF TTM 712.0m / Enterprise Value 10.64b)
FCF Margin = 23.65% (FCF TTM 712.0m / Revenue TTM 3.01b)
Net Margin = 20.70% (Net Income TTM 623.0m / Revenue TTM 3.01b)
Gross Margin = 48.54% ((Revenue TTM 3.01b - Cost of Revenue TTM 1.55b) / Revenue TTM)
Gross Margin QoQ = 47.76% (prev 47.47%)
Tobins Q-Ratio = 1.75 (Enterprise Value 10.64b / Total Assets 6.08b)
Interest Expense / Debt = 0.86% (Interest Expense 25.0m / Debt 2.92b)
Taxrate = 32.65% (48.0m / 147.0m)
NOPAT = 603.4m (EBIT 896.0m * (1 - 32.65%))
Current Ratio = 4.85 (Total Current Assets 2.23b / Total Current Liabilities 460.0m)
Debt / Equity = 1.56 (Debt 2.92b / totalStockholderEquity, last quarter 1.87b)
Debt / EBITDA = 1.40 (Net Debt 1.43b / EBITDA 1.01b)
Debt / FCF = 2.00 (Net Debt 1.43b / FCF TTM 712.0m)
Total Stockholder Equity = 1.78b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.91% (Net Income 623.0m / Total Assets 6.08b)
RoE = 34.97% (Net Income TTM 623.0m / Total Stockholder Equity 1.78b)
RoCE = 19.20% (EBIT 896.0m / Capital Employed (Equity 1.78b + L.T.Debt 2.88b))
RoIC = 14.02% (NOPAT 603.4m / Invested Capital 4.30b)
WACC = 7.47% (E(9.21b)/V(12.13b) * Re(9.66%) + D(2.92b)/V(12.13b) * Rd(0.86%) * (1-Tc(0.33)))
Discount Rate = 9.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.82%
[DCF] Terminal Value 81.57% ; FCFF base≈690.4m ; Y1≈752.9m ; Y5≈949.8m
[DCF] Fair Price = 208.6 (EV 18.70b - Net Debt 1.43b = Equity 17.27b / Shares 82.8m; r=7.47% [WACC]; 5y FCF grow 10.30% → 3.0% )
EPS Correlation: 37.50 | EPS CAGR: -1.69% | SUE: -1.55 | # QB: 0
Revenue Correlation: 51.50 | Revenue CAGR: 2.29% | SUE: 0.30 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.48 | Chg7d=+0.000 | Chg30d=+2.480 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=9.44 | Chg7d=+0.000 | Chg30d=-1.079 | Revisions Net=-2 | Growth EPS=+24.4% | Growth Revenue=+91.1%
EPS next Year (2027-12-31): EPS=11.68 | Chg7d=-0.308 | Chg30d=+0.069 | Revisions Net=+0 | Growth EPS=+23.7% | Growth Revenue=+5.1%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.0% (Discount Rate 9.7% - Earnings Yield 6.6%)
[Growth] Growth Spread = +85.1% (Analyst 88.1% - Implied 3.0%)
P/E Forward = 12.3457
P/S = 3.0609
P/B = 4.9098
P/EG = 0.6667
Revenue TTM = 3.01b USD
EBIT TTM = 896.0m USD
EBITDA TTM = 1.01b USD
Long Term Debt = 2.88b USD (from longTermDebt, last quarter)
Short Term Debt = 10.0m USD (from shortTermDebt, last quarter)
Debt = 2.92b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.43b USD (from netDebt column, last quarter)
Enterprise Value = 10.64b USD (9.21b + Debt 2.92b - CCE 1.50b)
Interest Coverage Ratio = 9.74 (Ebit TTM 896.0m / Interest Expense TTM 92.0m)
EV/FCF = 14.94x (Enterprise Value 10.64b / FCF TTM 712.0m)
FCF Yield = 6.69% (FCF TTM 712.0m / Enterprise Value 10.64b)
FCF Margin = 23.65% (FCF TTM 712.0m / Revenue TTM 3.01b)
Net Margin = 20.70% (Net Income TTM 623.0m / Revenue TTM 3.01b)
Gross Margin = 48.54% ((Revenue TTM 3.01b - Cost of Revenue TTM 1.55b) / Revenue TTM)
Gross Margin QoQ = 47.76% (prev 47.47%)
Tobins Q-Ratio = 1.75 (Enterprise Value 10.64b / Total Assets 6.08b)
Interest Expense / Debt = 0.86% (Interest Expense 25.0m / Debt 2.92b)
Taxrate = 32.65% (48.0m / 147.0m)
NOPAT = 603.4m (EBIT 896.0m * (1 - 32.65%))
Current Ratio = 4.85 (Total Current Assets 2.23b / Total Current Liabilities 460.0m)
Debt / Equity = 1.56 (Debt 2.92b / totalStockholderEquity, last quarter 1.87b)
Debt / EBITDA = 1.40 (Net Debt 1.43b / EBITDA 1.01b)
Debt / FCF = 2.00 (Net Debt 1.43b / FCF TTM 712.0m)
Total Stockholder Equity = 1.78b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.91% (Net Income 623.0m / Total Assets 6.08b)
RoE = 34.97% (Net Income TTM 623.0m / Total Stockholder Equity 1.78b)
RoCE = 19.20% (EBIT 896.0m / Capital Employed (Equity 1.78b + L.T.Debt 2.88b))
RoIC = 14.02% (NOPAT 603.4m / Invested Capital 4.30b)
WACC = 7.47% (E(9.21b)/V(12.13b) * Re(9.66%) + D(2.92b)/V(12.13b) * Rd(0.86%) * (1-Tc(0.33)))
Discount Rate = 9.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.82%
[DCF] Terminal Value 81.57% ; FCFF base≈690.4m ; Y1≈752.9m ; Y5≈949.8m
[DCF] Fair Price = 208.6 (EV 18.70b - Net Debt 1.43b = Equity 17.27b / Shares 82.8m; r=7.47% [WACC]; 5y FCF grow 10.30% → 3.0% )
EPS Correlation: 37.50 | EPS CAGR: -1.69% | SUE: -1.55 | # QB: 0
Revenue Correlation: 51.50 | Revenue CAGR: 2.29% | SUE: 0.30 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.48 | Chg7d=+0.000 | Chg30d=+2.480 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=9.44 | Chg7d=+0.000 | Chg30d=-1.079 | Revisions Net=-2 | Growth EPS=+24.4% | Growth Revenue=+91.1%
EPS next Year (2027-12-31): EPS=11.68 | Chg7d=-0.308 | Chg30d=+0.069 | Revisions Net=+0 | Growth EPS=+23.7% | Growth Revenue=+5.1%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.0% (Discount Rate 9.7% - Earnings Yield 6.6%)
[Growth] Growth Spread = +85.1% (Analyst 88.1% - Implied 3.0%)